MedsFacts Meta-Analysis covering adverse side effect reports of CONCOR COR (BISOPROLOL) patients who developed DRUG INTERACTION.
Introduction: MedsFacts provides MD-approved analysis to help both patients and physicians accurately research and assess the risk-reward trade off for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration, social media, and MedsFacts user submissions. Between January 2004 and October 2012, 3 individuals taking CONCOR COR (BISOPROLOL) reported DRUG INTERACTION to the FDA. A total of 11 CONCOR COR (BISOPROLOL) drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.
Topics covered: This page is designed to help you determine the relationship, if any, between CONCOR COR (BISOPROLOL) and DRUG INTERACTION. In doing so, we compare CONCOR COR (BISOPROLOL) with other drugs that cause DRUG INTERACTION, to help you evaluate whether or not CONCOR COR (BISOPROLOL) causes DRUG INTERACTION. Likewise, this page shows the most highly-reported side effects of CONCOR COR (BISOPROLOL), so you can see if DRUG INTERACTION ranks among CONCOR COR (BISOPROLOL)'s most well-known side effects.
The Dashboard explained: The Dashboard first shows general Summary Statistics for CONCOR COR (BISOPROLOL) and DRUG INTERACTION, such as the raw number and percentage of patients in FDA reports who used CONCOR COR (BISOPROLOL) and developed DRUG INTERACTION. Next, the Dashboard lists the most common reasons (indications) why CONCOR COR (BISOPROLOL) was prescribed for patients. We then display a pie-chart which shows, in aggregate, what we believe represents general physician opinion of the safety of CONCOR COR (BISOPROLOL). This pie-chart summarizes, for all FDA reports covering CONCOR COR (BISOPROLOL), whether or not the treating physician felt CONCOR COR (BISOPROLOL) (versus other drugs the patient was taking) was responsible for the adverse side-effects. After the pie-chart, we itemize the most common side effects in FDA studies covering CONCOR COR (BISOPROLOL). You may click on any of these side effects to learn more about them, in general, or specifically for CONCOR COR (BISOPROLOL). Finally, we identify the drugs most widely associated with CONCOR COR (BISOPROLOL) in FDA literature. You may also click on any of these drugs to view it's dashboard.
Reports of CONCOR COR (BISOPROLOL) causing DRUG INTERACTION: 3
Reports of any side effect of CONCOR COR (BISOPROLOL) : 11
Percentage of CONCOR COR (BISOPROLOL) patients where DRUG INTERACTION is a reported side effect: 27.272727272727%
FDA reports of any drug causing DRUG INTERACTION : 50284
Average percentage for all medicated patients where DRUG INTERACTION is reported as a complication: 0.3151504288005%
Most frequent diagnoses/indications for prescribing CONCOR COR (BISOPROLOL):
( 0 patients )
Physician opinion on CONCOR COR (BISOPROLOL) as adverse event culprit:
Most common side effects for patients taking CONCOR COR (BISOPROLOL):
MYALGIA (3 patients)
DRUG INTERACTION (3 patients)
VERTIGO (2 patients)
INITIAL INSOMNIA (2 patients)
PALPITATIONS (2 patients)
PARAESTHESIA (2 patients)
DIZZINESS (2 patients)
DISTURBANCE IN ATTENTION (2 patients)
HYPERKALAEMIA (2 patients)
ASTHENIA (2 patients)
Twitter feed for CONCOR COR (BISOPROLOL) - Pending/Beta
Drugs with high reportage of DRUG INTERACTION:
ASPIRIN (3975 patients)
SIMVASTATIN (3016 patients)
WARFARIN SODIUM (2875 patients)
OMEPRAZOLE (2503 patients)
FUROSEMIDE (2320 patients)
SEROQUEL (1748 patients)
LYRICA (1746 patients)
LEVOTHYROXINE SODIUM (1683 patients)
RAMIPRIL (1663 patients)
ACETAMINOPHEN (1551 patients)
Basic reports are available, free of charge, in PDF format and are suitable for scientific publication. Further data and analytics are available upon request. We are in the process of adding new features to our site, including Q&A interface for patients to speak with experts on medication. Check back with us again in the near future to see.